Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 9 studies | 29% ± 11% | |
| fibroblast | 8 studies | 24% ± 12% | |
| plasmablast | 7 studies | 39% ± 21% | |
| epithelial cell | 7 studies | 41% ± 15% | |
| epithelial cell of proximal tubule | 6 studies | 37% ± 9% | |
| endothelial cell | 6 studies | 25% ± 9% | |
| transit amplifying cell | 5 studies | 21% ± 3% | |
| erythroblast | 5 studies | 29% ± 10% | |
| connective tissue cell | 5 studies | 25% ± 8% | |
| ciliated cell | 5 studies | 35% ± 7% | |
| goblet cell | 5 studies | 27% ± 8% | |
| basal cell | 5 studies | 34% ± 16% | |
| abnormal cell | 4 studies | 25% ± 8% | |
| conventional dendritic cell | 3 studies | 31% ± 10% | |
| hematopoietic precursor cell | 3 studies | 26% ± 5% | |
| non-classical monocyte | 3 studies | 22% ± 4% | |
| enterocyte | 3 studies | 23% ± 4% | |
| mesothelial cell | 3 studies | 32% ± 20% | |
| macrophage | 3 studies | 26% ± 6% | |
| dendritic cell | 3 studies | 38% ± 2% | |
| intestinal crypt stem cell | 3 studies | 21% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 6944.81 | 226 / 226 | 100% | 79.59 | 406 / 406 |
| thymus | 100% | 2111.43 | 653 / 653 | 100% | 33.38 | 604 / 605 |
| uterus | 100% | 1300.61 | 170 / 170 | 100% | 52.29 | 458 / 459 |
| ovary | 100% | 1144.74 | 180 / 180 | 100% | 44.51 | 429 / 430 |
| kidney | 100% | 3998.55 | 89 / 89 | 100% | 55.36 | 898 / 901 |
| adrenal gland | 100% | 2524.63 | 258 / 258 | 100% | 58.95 | 229 / 230 |
| brain | 100% | 1636.62 | 2638 / 2642 | 100% | 28.72 | 702 / 705 |
| stomach | 100% | 1620.41 | 359 / 359 | 99% | 35.99 | 284 / 286 |
| intestine | 100% | 2705.48 | 966 / 966 | 99% | 43.27 | 523 / 527 |
| prostate | 100% | 2167.71 | 245 / 245 | 99% | 42.79 | 497 / 502 |
| pancreas | 100% | 1169.77 | 328 / 328 | 99% | 34.65 | 176 / 178 |
| breast | 100% | 1899.08 | 459 / 459 | 99% | 38.79 | 1104 / 1118 |
| skin | 100% | 1816.72 | 1808 / 1809 | 99% | 44.69 | 465 / 472 |
| bladder | 100% | 2117.43 | 21 / 21 | 98% | 49.64 | 496 / 504 |
| esophagus | 100% | 2153.27 | 1445 / 1445 | 98% | 19.73 | 179 / 183 |
| lung | 99% | 1368.69 | 571 / 578 | 98% | 33.45 | 1134 / 1155 |
| adipose | 100% | 2114.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 40.55 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 66.06 | 29 / 29 |
| spleen | 100% | 2535.19 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 52.23 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 26.15 | 1 / 1 |
| muscle | 100% | 2233.99 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 2196.13 | 851 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1116.17 | 1318 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 55% | 768.22 | 510 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031648 | Biological process | protein destabilization |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ISOC2 |
| Protein name | Isochorismatase domain-containing protein 2 Isochorismatase domain containing 2 |
| Synonyms | |
| Description | |
| Accessions | K7ENV7 Q96AB3 ENST00000587226.5 ENST00000438389.6 [Q96AB3-3] ENST00000085068.7 [Q96AB3-2] K7EKW4 ENST00000589080.1 ENST00000425675.7 [Q96AB3-1] |